Ellias Helen K.
CIK: 0002001600
Director
Primary company: SAB Biotherapeutics, Inc. (SABS)
Ellias Helen K. is a corporate insider at SAB Biotherapeutics, Inc. (SABS) filing SEC Form 4 transactions. 5 transactions. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 150,000 | - | - | 150,000 | 12/16/2025 Filed: 12/18/2025 | Filing → | |
| Award | 35,000 | - | - | 35,000 | 11/1/2024 Filed: 11/5/2024 | Filing → | |
| Award | 20,000 | - | - | 20,000 | 11/1/2024 Filed: 11/5/2024 | Filing → | |
| Exercise | 1,800 | $1000.00 | $1.80M | 0 | 11/24/2023 Filed: 11/28/2023 | Filing → | |
| Exercise | 2,857,142 | - | - | 2,857,142 | 11/24/2023 Filed: 11/28/2023 | Filing → |
Type
Award
Shares
150,000
Price
-
Value
-
Type
Award
Shares
35,000
Price
-
Value
-
Type
Award
Shares
20,000
Price
-
Value
-
Type
Exercise
Shares
1,800
Price
$1000.00
Value
$1.80M
Type
Exercise
Shares
2,857,142
Price
-
Value
-
AI Agent
Try asking...